GlaxoSmithKline Settles Avandia Drug Heart Attack Death Suit on Eve of First Trial

January 31, 2011 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Bloomberg -- GlaxoSmithKline Plc said it settled on the eve of trial a lawsuit alleging its Avandia diabetes drug caused a North Carolina man to die of a heart attack, avoiding a jury determination over risks associated with the medicine.

Twitter
LinkedIn
Facebook
Email
Print

Legal

GlaxoSmithKline